NDC product
CCDB
NDC 26436-5632 · Hybrid Pharma
Key facts
| Product NDC | 26436-5632 |
|---|---|
| Proprietary name | CCDB |
| Nonproprietary name | Ciprofloxacin 40.7% Clotrimazole 40.7% Dexamethasone 3.4% Boric acid 15.2% |
| Substances | CIPROFLOXACIN, DEXAMETHASONE, CLOTRIMAZOLE |
| Dosage form | POWDER |
| Route | AURICULAR (OTIC) |
| Labeler | Hybrid Pharma |
| Product type | HUMAN COMPOUNDED DRUG |
| Marketing category | OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory